Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$31.84 - $50.88 $3.04 Million - $4.86 Million
-95,564 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$42.0 - $59.29 $4.01 Million - $5.67 Million
95,564 New
95,564 $0
Q2 2018

Aug 13, 2018

SELL
$27.2 - $74.35 $2.72 Million - $7.43 Million
-100,000 Closed
0 $0
Q1 2018

May 10, 2018

BUY
$24.05 - $37.5 $1.87 Million - $2.92 Million
77,893 Added 352.35%
100,000 $2.99 Million
Q4 2017

Feb 12, 2018

BUY
$26.0 - $34.6 $574,782 - $764,902
22,107
22,107 $735,000

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $319M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.